X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Lao PDR to Improve Health and Nutrition for Mothers and Children, with World Bank Support

Content Team by Content Team
1st November 2017
in Health & Nutrition

The World Bank is strengthening support to a project that is expected to improve the health of more than one million people across 14 provinces in Lao PDR.

US$15 million in additional financing, approved today by the World Bank’s Board of Executive Directors, will further support the ongoing Health Governance and Nutrition Development Project (HGNDP), which aims to establish a unified approach to healthcare information systems that enable senior policymakers in the Ministry of Health to plan better. The project builds on an earlier initiative that successfully increased access to healthcare for reproductive, maternal and child health, and nutrition services in targeted areas of the country.

 

“Improving healthcare and nutrition outcomes is a key priority for us to help us meet our goal of graduating from Least Developed Country status by the year 2020 and becoming an upper-middle-income country by 2030,” said Dr. Kikeo Chanthaboury, Vice Minister of Planning and Investment.

The ongoing project, which began in 2015, introduced innovative results-based financing approaches aimed to accelerate policy change, improve delivery of maternal and child health services, and achieve better health outcomes.

With additional financing, the project will further improve health management and data systems at the subnational level and strengthen immunization coverage, especially in lagging areas, as well as support a national campaign to encourage behavioral change towards nutrition.

“Some 44 percent of all children under five in Lao PDR suffer from stunting – no income group is spared. The future of the country is dependent on our collective efforts to prioritize improving the health and nutrition of the very young and the women who provide for them, as well as expectant women,” said Ellen Goldstein, World Bank Country Director for Cambodia, Lao PDR, and Myanmar.

Additional financing of US$10 million comes as a credit from International Development Association. The remaining amount is comprised of a US$4 million grant from the Integrating Donor-Financed Health Program (drawing on the Government of Australia’s contribution to the trust fund), which focuses on strengthening immunization systems, and US$1 million from the Government of Japan, earmarked to focus on improving information systems and monitoring health programs.

The World Bank currently finances 18 projects in Lao PDR in a variety of sectors. Investing in People is one of the key areas of the World Bank’s Country Partnership Framework 2017-2021, with the objectives of reducing the prevalence of malnutrition and improving access to and quality of health services.

Previous Post

Phase 3 Study Of Subcutanous Daratumumab Initiated Using Halozyme's ENHANZE Technology

Next Post

PCI Announces Further Investment in Fully Contained Xcelodose® 600S Technology Delivering Excellence in Clinical Services

Related Posts

Bio-Gate and Avicanna complete first phase of development on CBD and Micro Silver BG based skin care products for global commercialization
Health & Nutrition

Bio-Gate and Avicanna complete first phase of development on CBD and Micro Silver BG based skin care products for global commercialization

30th June 2021
Good nutrition can contribute to keeping COVID-19 and other diseases away
Health & Nutrition

Good nutrition can contribute to keeping COVID-19 and other diseases away

12th October 2020
Danone Ltd invests €100m in specialized nutrition in China
Health & Nutrition

Danone Ltd invests €100m in specialized nutrition in China

20th July 2020
DuPont Nutrition & Biosciences Enters into Collaboration with Microbiome Specialist MRM Health
Health & Nutrition

DuPont Nutrition & Biosciences Enters into Collaboration with Microbiome Specialist MRM Health

25th February 2020
Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health
Health & Nutrition

Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health

24th January 2020
Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK
Health & Nutrition

Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

7th January 2020
Next Post

PCI Announces Further Investment in Fully Contained Xcelodose® 600S Technology Delivering Excellence in Clinical Services

Latest News

FDA Experts Recommend Changing COVID Jab Formulation In Fall
Manufacturing

FDA Experts Recommend Changing COVID Jab Formulation In Fall

30th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis To Slash 8,000 Jobs To Save $1 Billion By 2024

30th June 2022
How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace
Manufacturing

How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace

27th June 2022
Australia Creates A Novel Stem Cell Production Technique
Manufacturing

Australia Creates A Novel Stem Cell Production Technique

27th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis Promises $250M For Tropical Illnesses, Malaria

27th June 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In